Priyanka Acharya

Clinical Research Institute, Methodist Dallas Medical Center

Papers

Total Citations

H-Index

About

Priyanka Acharya is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for pancreatic cancer treatment, particularly through robotic surgery. Her major contributions center on evaluating the safety, efficacy, and long-term outcomes of robotic pancreaticoduodenectomy (RPD) compared to traditional open surgery. In her landmark study, "Analysis of 102 Fully Robotic Pancreaticoduodenectomies" (2020, 21 citations), she provided critical insights into clinical outcomes and financial variables, demonstrating that RPD can be performed safely at high-volume centers with comparable results to open procedures. Acharya further solidified her impact with a propensity score-weighted survival analysis (2022, 11 citations) specifically examining pancreatic ductal adenocarcinoma patients, offering compelling evidence that robotic approaches do not compromise oncologic outcomes. Her work has been instrumental in shaping the adoption of robotic surgery in pancreatic oncology, addressing key questions about feasibility, cost-effectiveness, and survival. Through rigorous retrospective analyses and advanced statistical methods, Acharya has helped define the role of robotics in pancreatic surgery, making her a notable voice in the ongoing evolution of surgical oncology.